Samreen I. Ahmed
Aligarh Muslim University · 119 works · 3,834 citations · h-index 28
Top works
- Osimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLC
- Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence
- Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non–Small-Cell Lung Cancer in CheckMate 227
- Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non–small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial
- Principles of cancer treatment by chemotherapy
- Effects of a self-managed home-based walking intervention on psychosocial health outcomes for breast cancer patients receiving chemotherapy: a randomised controlled trial
- Studies on the Expression of Endothelin, Its Receptor Subtypes, and Converting Enzymes in Lung Cancer and in Human Bronchial Epithelium
- Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer
- Vascular Endothelial Growth Factor (VEGF) Inhibition by Small Molecules
- Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non–Small-Cell Lung Cancer: ERCC1 Trial (ET)
- Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients
- Growth fraction as a predictor of response to chemotherapy in node‐negative breast cancer
- A comparison of Infections and Complications in Central Venous Catheters in Adults with Solid Tumours
- Cognitive Intervention for Breast Cancer Patients Undergoing Adjuvant Chemotherapy
- A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor (MTGI™), in patients with advanced solid tumours
- Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT)
- An Association of Cancer Physicians’ strategy for improving services and outcomes for cancer patients
- A new strain of rat for functional analysis of PINA
- Optimising tissue acquisition and the molecular testing pathway for patients with non-small cell lung cancer: A UK expert consensus statement
- Does walking protect against decline in cognitive functioning among breast cancer patients undergoing chemotherapy? Results from a small randomised controlled trial